Similar articles

• Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis.

  Sonnenblick A, Shriki A, Galun E, Axelrod JH, Daum H, Rottenberg Y, Hamburger T, Mali B, Peretz T. Sonnenblick A, et al. Clin Transl Oncol. 2012 Mar;14(3):232-6. doi: 10.1007/s12094-012-0789-z. Clin Transl Oncol. 2012. PMID: 22374428
• Survivin as a predictive biomarker of complete pathologic response to neoadjuvant chemotherapy in patients with stage II and stage III breast cancer.

  Petrarca CR, Brunetto AT, Duval V, Brondani A, Carvalho GP, Garicochea B. Petrarca CR, et al. Clin Breast Cancer. 2011 Apr;11(2):129-34. doi: 10.1016/j.clbc.2011.03.002. Epub 2011 Apr 11. Clin Breast Cancer. 2011. PMID: 21569999
• Development of candidate genomic markers to select breast cancer patients for dasatinib therapy.

  Moulder S, Yan K, Huang F, Hess KR, Liedtke C, Lin F, Hatzis C, Hortobagyi GN, Symmans WF, Pusztai L. Moulder S, et al. Mol Cancer Ther. 2010 May;9(5):1120-7. doi: 10.1158/1535-7163.MCT-09-1117. Epub 2010 Apr 27. Mol Cancer Ther. 2010. PMID: 20423993
• Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?

  Romero A, Caldés T, Díaz-Rubio E, Martín M. Romero A, et al. Clin Transl Oncol. 2012 Mar;14(3):163-8. doi: 10.1007/s12094-012-0779-1. Clin Transl Oncol. 2012. PMID: 22374418 Review.
• Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis.

  Belkouz A, Labeur TA, Dierks J, Dijk F, van Oijen MGH, Verheij J, van Gulik TM, van de Vijver MJ, Wilmink H, Punt CJA, Klümpen HJ. Belkouz A, et al. Crit Rev Oncol Hematol. 2019 Sep;141:82-94. doi: 10.1016/j.critrevonc.2019.06.001. Epub 2019 Jun 8. Crit Rev Oncol Hematol. 2019. PMID: 31255992